Pneumococcal Polysaccharide Vaccine Market Report

Global and Region Pneumococcal Polysaccharide Vaccine Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：214
  • REPORT CODE：GMM964401
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Pneumococcal disease is an infection caused by the Streptococcus pneumoniae bacteria, which especially affects infants and children below 5 years of age.

    The major factors that contribute to the growth of the pneumococcal polysaccharide vaccine market include increasing prevalence of pneumonia globally, improving healthcare infrastructure, rise in government focus on immunization programs for pneumonia, and development of quality vaccines such as PPSV23.

    The report details the trend, potential and market size of Pneumococcal Polysaccharide Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pneumococcal Polysaccharide Vaccinemarket, defines the market attractiveness level of Pneumococcal Polysaccharide Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pneumococcal Polysaccharide Vaccine industry, describes the types of Pneumococcal Polysaccharide Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pneumococcal Polysaccharide Vaccine market and the development prospects and opportunities of Pneumococcal Polysaccharide Vaccine industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pneumococcal Polysaccharide Vaccine market in Chapter 13.

    By Player:

    • Pfizer Inc

    • China National Biotec Group

    • Glaxosmithkline Plc

    • Merck & Co, Inc

    • Serum Institute of India Pvt Ltd

    • Astellas Pharma Inc

    • Sanofi Pasteur

    By Type:

    • Single Dose Vial

    • Pre-filled Syringe

    By End-User:

    • Children (2-10 Age)

    • Adult (10-64 Age)

    • Geriatric (More Than 65 Age)

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pneumococcal Polysaccharide Vaccine Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pneumococcal Polysaccharide Vaccine Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pneumococcal Polysaccharide Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pneumococcal Polysaccharide Vaccine Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook to 2022

    • 7.1 Global Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.2 United States Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.3 Europe Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.4 China Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.5 Japan Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.6 India Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    • 7.7 South Korea Pneumococcal Polysaccharide Vaccine Consumption (2017-2022)

    8 Region and Country-wise Pneumococcal Polysaccharide Vaccine Market Analysis and Outlook to 2028

    • 8.1 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.2 United States Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.3 Europe Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.4 China Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.5 Japan Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.6 India Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    • 8.7 South Korea Pneumococcal Polysaccharide Vaccine Consumption Forecast (2022-2028)

    9 Global Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2022

    • 9.1 Global Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Single Dose Vial Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children (2-10 Age) Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult (10-64 Age) Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Geriatric (More Than 65 Age) Consumption and Growth Rate (2017-2022)

    10 Global Pneumococcal Polysaccharide Vaccine Market Outlook by Types and Applications to 2028

    • 10.1 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Children (2-10 Age) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Adult (10-64 Age) Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Geriatric (More Than 65 Age) Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pneumococcal Polysaccharide Vaccine Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pneumococcal Polysaccharide Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pneumococcal Polysaccharide Vaccine Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pneumococcal Polysaccharide Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pneumococcal Polysaccharide Vaccine Market Competitive Analysis

    • 14.1 Pfizer Inc

      • 14.1.1 Pfizer Inc Company Details

      • 14.1.2 Pfizer Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Pfizer Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.2 China National Biotec Group

      • 14.2.1 China National Biotec Group Company Details

      • 14.2.2 China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 China National Biotec Group Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.3 Glaxosmithkline Plc

      • 14.3.1 Glaxosmithkline Plc Company Details

      • 14.3.2 Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.4 Merck & Co, Inc

      • 14.4.1 Merck & Co, Inc Company Details

      • 14.4.2 Merck & Co, Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck & Co, Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.5 Serum Institute of India Pvt Ltd

      • 14.5.1 Serum Institute of India Pvt Ltd Company Details

      • 14.5.2 Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.6 Astellas Pharma Inc

      • 14.6.1 Astellas Pharma Inc Company Details

      • 14.6.2 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • 14.7 Sanofi Pasteur

      • 14.7.1 Sanofi Pasteur Company Details

      • 14.7.2 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pneumococcal Polysaccharide Vaccine

    • Figure Pneumococcal Polysaccharide Vaccine Picture

    • Table Global Pneumococcal Polysaccharide Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pneumococcal Polysaccharide Vaccine Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pneumococcal Polysaccharide Vaccine Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pneumococcal Polysaccharide Vaccine Consumption by Country (2017-2022)

    • Figure United States Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Table Europe Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure China Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Japan Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure India Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pneumococcal Polysaccharide Vaccine Consumption and Growth Rate (2017-2022)

    • Figure Global Pneumococcal Polysaccharide Vaccine Consumption Forecast by Country (2022-2028)

    • Figure United States Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pneumococcal Polysaccharide Vaccine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Single Dose Vial Consumption and Growth Rate (2017-2022)

    • Figure Global Pre-filled Syringe Consumption and Growth Rate (2017-2022)

    • Figure Global Children (2-10 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Adult (10-64 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Geriatric (More Than 65 Age) Consumption and Growth Rate (2017-2022)

    • Figure Global Single Dose Vial Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pre-filled Syringe Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children (2-10 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult (10-64 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Geriatric (More Than 65 Age) Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pneumococcal Polysaccharide Vaccine Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pneumococcal Polysaccharide Vaccine Export by Region (Top 5 Countries) (2017-2028)

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • Table China National Biotec Group (Foundation Year, Company Profile and etc.)

    • Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table China National Biotec Group Pneumococcal Polysaccharide Vaccine Product and Service

    • Table Glaxosmithkline Plc (Foundation Year, Company Profile and etc.)

    • Table Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Glaxosmithkline Plc Pneumococcal Polysaccharide Vaccine Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • Table Serum Institute of India Pvt Ltd (Foundation Year, Company Profile and etc.)

    • Table Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Serum Institute of India Pvt Ltd Pneumococcal Polysaccharide Vaccine Product and Service

    • Table Astellas Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma Inc Pneumococcal Polysaccharide Vaccine Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US